The authorization is limited to testing performed at the Rutgers Clinical Genomics Laboratory using their molecular LDT COVID-19 authorized test for saliva specimens collected using the Spectrum Solutions LLC SDNA-1000 Saliva Collection Device. FDA states “It is important to note that this is not a general authorization for at-home collection of patient samples using other collection methods, saliva collection devices, or tests, or for tests fully conducted at home.”
Sofia® 2 SARS Antigen FIA Point-of-Care test offers positive results in 15 minutesContinue reading
With Mother’s Day just around the corner, BIO sat down with Dr. Mary-Ann Etiebet, Executive Director of Merck for Mothers, for a discussion about how Merck helping address maternal health needs in the United States and in countries impacted by COVID-19. Continue reading
Led by diagnostics industry veteran Mara G. Aspinall, Health Catalysts Group is an Arizona based consulting and informatics firm focused on the success of life sciences companies.
A paper published in two medical journals last week offers guidelines for physicians treating coronavirus patients requiring advanced life-saving therapies.Continue reading
Established combination seen as safer option for coronavirus therapy; will add data to TGen COVID Immunity Study and virus sequencing effortsContinue reading
USPTO launches platform to facilitate connections between patent holders and potential licensees in key technologies. Initial release focuses on COVID-19–related technologiesContinue reading
- First participants dosed at NYU Grossman School of Medicine and University of Maryland School of Medicine
- Pfizer and BioNTech ramping up manufacturing capabilities to further increase production capacity in 2020/2021
Research projects will address the pandemic from various angles, including public health, virology and drug discovery.
New portal developed with the Aerospace Industries Association and Google connects ventilator component suppliers with manufacturersContinue reading